← Leaderboards
Philip Ng
Baylor College Of Medicine
$7,705,481
Attributed
$7,705,481
Total exposure
15
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$7,705,481 · 15
By mechanism
R01$6,381,037 · 2
P51$682,777 · 12
P01$641,667 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Michael A Barry$17,628,136
- Brendan Hl Lee$62,781,623
- Lawrence Chan$23,286,228
- Kazuhiro Oka$2,025,761
- Masataka Suzuki$902,239
Others in their field
Top investigators on “Vector”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- David Heimbrook · Leidos Biomedical Research, Inc.$141,066,079
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,296,230
- Philip Goode · New Jersey Institute Of Technology$73,697,028
Research focus
VectorDoseGene TherapyToxic EffectHelper-Dependent Adenoviral VectorSafetyLiverAcutePapioTransgene ExpressionGene TransferGrantAnimalsHepatocyteProceduresInjection Of Therapeutic AgentOrganNonhuman PrimatePrimatesTransduction EfficiencyFundingResourcesMediatingSource
Grant awards (27)
Improving Safety and Efficacy of Gene Therapy with HDAd$497,765
R01 · FY2013 · DK · contact PI
Improving Safety and Efficacy of Gene Therapy with HDAd$515,542
R01 · FY2012 · DK · contact PI
Improving Safety and Efficacy of Gene Therapy with HDAd$459,321
R01 · FY2011 · DK · contact PI
DELIVERY OF HD-AD VECTORS TO PRIMATE LUNG$171,015
P51 · FY2011 · RR · contact PI
GENE THERAPY IN BABOONS$144,769
P51 · FY2011 · RR · contact PI
Aerosol delivery of HDAd into Primate Lungs: Preclinical CF Gene Therapy Studies$721,513
R01 · FY2010 · HL · contact PI
Improving Safety and Efficacy of Gene Therapy with HDAd$610,864
R01 · FY2010 · DK · contact PI
LIVER-EXCLUSIVE TRANSDUCTION WITH HDAD VECTORS FOR GENE THERAPY$65,025
P51 · FY2010 · RR · contact PI
DELIVERY OF HD-AD VECTORS TO PRIMATE LUNG$60,761
P51 · FY2010 · RR · contact PI
GENE THERAPY IN BABOONS$9,594
P51 · FY2010 · RR · contact PI
Aerosol delivery of HDAd into Primate Lungs: Preclinical CF Gene Therapy Studies$729,111
R01 · FY2009 · HL · contact PI
Improving safety and efficacy of gene therapy with HDAd$348,355
R01 · FY2009 · DK · contact PI
DELIVERY OF HD-AD VECTORS TO PRIMATE LUNG$82,265
P51 · FY2009 · RR · contact PI
GENE THERAPY IN BABOONS$45,580
P51 · FY2009 · RR · contact PI
Aerosol delivery of HDAd into Primate Lungs: Preclinical CF Gene Therapy Studies$704,125
R01 · FY2008 · HL · contact PI
Improving safety and efficacy of gene therapy with HDAd$298,520
R01 · FY2008 · DK · contact PI
LIVER-EXCLUSIVE TRANSDUCTION WITH HDAD VECTORS FOR GENE THERAPY$7,105
P51 · FY2008 · RR · contact PI
GENE THERAPY IN BABOONS$3,045
P51 · FY2008 · RR · contact PI
DELIVERY OF HD-AD VECTORS TO PRIMATE LUNG$2,601
P51 · FY2008 · RR · contact PI
Aerosol delivery of HDAd into Primate Lungs: Preclinical CF Gene Therapy Studies$749,436
R01 · FY2007 · HL · contact PI
Improving the helper-dependent adenoviral vector system$381,761
P01 · FY2007 · HL · contact PI
Improving safety and efficacy of gene therapy with HDAd$279,703
R01 · FY2007 · DK · contact PI
GENE THERAPY IN BABOONS$89,903
P51 · FY2007 · RR · contact PI
Improving safety and efficacy of gene therapy with HDAd$222,292
R01 · FY2006 · DK · contact PI
DELIVERY OF HD-AD VECTORS TO PRIMATE LUNG$1,114
P51 · FY2006 · RR · contact PI
Improving safety and efficacy of gene therapy with HDAd$244,490
R01 · FY2005 · DK
Improving the helper-dependent adenoviral vector system$259,906
P01 · FY2003 · HL